文献速递医院感染防控细菌感染、耐药与抗菌药物

加拿大2015-2022年成人与儿童医疗相关及社区相关艰难梭菌感染特征

Characterization of Adult and Pediatric Healthcare-Associated and Community-Associated Clostridioides difficile Infections, Canada, 2015-2022.
PubMed 文献 · Emerg Infect Dis · 2025-01-01

研究分析了2015-2022年加拿大医院监测项目中30,824例艰难梭菌感染(CDI)病例,其中成人占94.9%(医疗相关73.2%,社区相关26.8%),儿童占5.1%(医疗相关77.6%,社区相关22.4%)。成人医疗相关CDI率下降19.9%,社区相关稳定;儿童医疗相关下降29.6%,社区相关下降58.3%。RT106成为最常见核糖体型并取代RT027,RT027与成人、医疗相关、重症CDI及严重结局最相关。

要点

  • 成人CDI以医疗相关为主(73.2%),儿童医疗相关占77.6%。
  • 研究期间成人医疗相关CDI率下降19.9%,儿童社区相关下降58.3%。
  • RT106取代RT027成为最主要核糖体型,RT027与重症及严重结局相关。

核心结论

  • RT106已成为成人和儿童CDI中最常见的核糖体型,并取代了RT027。
  • 成人医疗相关CDI率下降19.9%,儿童医疗相关和社区相关CDI率分别下降29.6%和58.3%。

研究设计与样本

  • 基于加拿大医院感染监测计划(CNISP)医院的监测研究,纳入2015-2022年成人和儿童CDI病例共30,824例。

主要发现

  • 30,824例CDI中,成人29,250例(94.9%),其中医疗相关73.2%、社区相关26.8%;儿童1,574例(5.1%),其中医疗相关77.6%、社区相关22.4%。
  • 研究期间成人医疗相关CDI率下降19.9%,社区相关CDI率保持稳定;儿童医疗相关CDI率下降29.6%,社区相关CDI率下降58.3%。
  • RT106在成人和儿童中均为最常见核糖体型,并取代RT027成为优势菌株。
  • RT027与成人患者、医疗相关获得、重症CDI及严重结局最相关。
  • 莫西沙星耐药在成人中高于儿童;克林霉素和利福平耐药率在两组间相似。

临床怎么用

  • 持续的国家监测对于理解加拿大成人和儿童CDI流行病学及指导预防工作至关重要。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We investigated epidemiologic and molecular characteristics of healthcare-associated (HA) and community-associated (CA) Clostridioides difficile infection (CDI) among adult and pediatric patients in Canadian Nosocomial Infection Surveillance Program hospitals during 2015-2022. Of 30,824 reported CDI cases, 94.9% (29,250/30,824) were among adult (73.2% HA; 26.8% CA) and 5.1% (1,574/30,824) pediatric (77.6% HA; 22.4% CA) patients. During the study period, adult HA CDI rates decreased by 19.9% and CA CDI rates remained stable; pediatric HA CDI rates decreased by 29.6% and CA CDI decreased by 58.3%. Ribotype (RT) 106 was most common among both groups and replaced RT027 as the predominant strain type. RT027 was most associated with adult patients, HA acquisition, severe CDI, and severe outcomes. Moxifloxacin resistance was higher in adult than pediatric cases; clindamycin and rifampin resistance rates were similar between groups. Continued national surveillance is integral to understanding the epidemiology of adult and pediatric CDI in Canada and informing prevention efforts.

来源:Emerg Infect Dis,查看原文。版权归原作者所有。

引用

  1. Du T, Silva A, Choi KB, et al. Characterization of Adult and Pediatric Healthcare-Associated and Community-Associated Clostridioides difficile Infections, Canada, 2015-2022. Emerg Infect Dis. 2025. PMID: 40439410. doi:10.3201/eid3106.250182

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。